Details for New Drug Application (NDA): 010496
✉ Email this page to a colleague
NDA 010496 describes XYLOCAINE 5% W/ GLUCOSE 7.5%, which is a drug marketed by Astrazeneca and is included in one NDA. Additional details are available on the XYLOCAINE 5% W/ GLUCOSE 7.5% profile page.
The generic ingredient in XYLOCAINE 5% W/ GLUCOSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
The generic ingredient in XYLOCAINE 5% W/ GLUCOSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 010496
| Tradename: | XYLOCAINE 5% W/ GLUCOSE 7.5% |
| Applicant: | Astrazeneca |
| Ingredient: | lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;SPINAL | Strength | 5% | ||||
| Approval Date: | Jul 7, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
